Cipla achieved generic Ventolin approval in the US and partnered with MannKind Corporation for inhaled insulin.
3 reports, 3 independent
Updated Aug 1
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cipla achieved generic Ventolin approval in the US and partnered with MannKind Corporation for inhaled insulin.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Cipla secured US generic Ventolin approval and formed a partnership with MannKind for inhaled insulin.1 source
Cipla commercialized generic Ventolin in India, expanding its generic drug portfolio.1 source
Keep exploring
The entities involved
-
Cipla
Indian multi-national pharmaceutical and biotechnology company
Nothing else this week.
-
MannKind Corporation
biopharmaceutical company
Coverage
Newest first; wire copies grouped- moneycontrol.com
- livemint.com
- indiatimes.comUS market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipeline